What is Expression Systems?
Expression Systems, LLC is a specialized biotechnology firm dedicated to enhancing baculovirus and host cell expression technologies. The company offers a comprehensive suite of products and services, including premium insect cell culture media, baculovirus, biological buffers, reagents, and molecular tools. Their flagship product, ESF AdvanCD, is designed to promote superior cell growth and consistent viral stock production. Expression Systems serves a global clientele within the biotechnology and pharmaceutical sectors, aiming to optimize research and development processes for expression technologists worldwide.
How much funding has Expression Systems raised?
Expression Systems has raised a total of $599K across 2 funding rounds:
Debt
$150K
Debt
$449K
Debt (2020): $150K with participation from PPP
Debt (2021): $449K led by PPP
Key Investors in Expression Systems
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Expression Systems?
With the recent strategic investment, Expression Systems is poised for accelerated growth and innovation in the biopharmaceutical sector. The company's focus on high-quality cell culture media and expression tools suggests a strategic direction towards supporting the development of novel therapeutics and biologics. This backing will likely enable Expression Systems to expand its product development, enhance its service offerings, and broaden its market reach, further solidifying its position as a key supplier for global biotechnology research and production.
See full Expression Systems company page
